Results 271 to 280 of about 17,654,627 (326)

ATF4‐mediated stress response as a therapeutic vulnerability in chordoma

open access: yesMolecular Oncology, EarlyView.
We screened 5 chordoma cell lines against 100+ inhibitors of epigenetic and metabolic pathways and kinases and identified halofuginone, a tRNA synthetase inhibitor. Mechanistically halofuginone induces an integrated stress response, with eIF2alpha phosphorylation, activation of ATF4 and its target genes CHOP, ASNS, INHBE leading to cell death ...
Lucia Cottone   +11 more
wiley   +1 more source

A subset of MMR‐proficient colon cancers responds to neoadjuvant immunotherapy

open access: yesMolecular Oncology, EarlyView.
Tan et al. reveal that a distinct subset of early‐stage pMMR colon cancers can respond to neoadjuvant immunotherapy. In the NICHE‐2 trial, responders (26%) were characterized by chromosomal instability, TP53 mutations, and proliferative cell‐cycle programs, whereas nonresponders showed metabolic and stromal reprogramming with TGF‐β‐driven ...
Eleonora Piumatti   +3 more
wiley   +1 more source

The human vaginal microbiota: from clinical medicine to models to mechanisms. [PDF]

open access: yesCurr Opin Microbiol
Ottinger S   +3 more
europepmc   +1 more source

Performance of ChatGPT on the Chinese Postgraduate Examination for Clinical Medicine: Survey Study.

open access: yesJMIR Med Educ
Yu P   +15 more
europepmc   +1 more source

Aerospace Medicine Clinic

Aerospace Medicine and Human Performance, 2021
Kreykes AJ, Vardiman J. Aerospace medicine clinic: aseptic meningitis. Aerosp Med Hum Perform. 2021; 92(10):845848.
Geoffrey, Garst M D M P H   +1 more
  +9 more sources

Clinical management of metastatic colorectal cancer in the era of precision medicine

open access: yesCa-A Cancer Journal for Clinicians, 2022
Colorectal cancer (CRC) represents approximately 10% of all cancers and is the second most common cause of cancer deaths. Initial clinical presentation as metastatic CRC (mCRC) occurs in approximately 20% of patients. Moreover, up to 50% of patients with
, Davide Ciardiello, Giulia Martini
exaly   +2 more sources

Home - About - Disclaimer - Privacy